The content of matrix metalloproteinase-1,-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity

被引:0
|
作者
Kachkovska, V. V. [1 ]
Prystupa, L. N. [2 ]
机构
[1] Sumy State Univ, Ctr Resp Med, Dept Internal Med, UA-40007 Sumy, Ukraine
[2] Sumy State Univ, Ctr Resp Med, Internal Med, Sumy, Ukraine
来源
PATHOLOGIA | 2023年 / 20卷 / 03期
关键词
asthma; obesity; matrix metalloproteinase-1; matrix metalloproteinase-9; tissue inhibitor of metalloproteinase-1; course; control;
D O I
10.14739/2310-1237.2023.3.291212
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Airway remodeling is a significant factor in the progression of respiratory failure in bronchial asthma (BA). Obesity can contribute to inflammation, and consequently - airway remodeling, by increased production of matrix proteinase (MMP). However, the mechanisms of remodeling in different phenotypes of BA, especially in comorbid patients, remain poorly understood.The aim of the research was to examine the levels of remodeling markers MMP-1, MMP-9 and tissue inhibitor of matrix proteinases (TIMP-1) in obese asthmatic patients, taking into account their age at the onset of BA, the severity of symptoms and the level of control. Material and methods. 195 patients with BA associated with obesity were examined. The control group consisted of 95 practically healthy people. Patients were divided into two groups: Group I included 100 patients with early onset, and Group II included 95 patients with late onset of BA. The study was approved by the Bioethics Commission of the Medical Institute of Sumy State University. Statistical analysis of the obtained results was carried out using the SPSS-17 program.Results. The content of MMP-1,-9 and TIMP-1 was higher in patients with early (129.40 +/- 7.86; 177.30 +/- 9.19; 142.40 +/- 12.22 ng/ml, respectively) and late (196.60 +/- 9.62; 289.80 +/- 16.23; 187.50 +/- 11.34 ng/ml, respectively) BA with obesity compared to practically healthy individuals (p < 0.005). Patients with late-onset BA associated with obesity likely had higher indicators than those with early BA. In patients with early BA, the levels of MMP-1,-9, and TIMP-1 were not significantly different depending on the severity of the disease (p > 0.05). However, in patients with severe late BA, the levels of these markers were higher compared to those with mild BA (p < 0.05). Levels of MMP-1 and MMP-9 in patients with early-onset and late-onset BA with obesity were higher in the absence of disease control compared to those in complete and partial control, but in late-onset exceeded those in early-onset.Conclusions. Considering the obtained results, it can be assumed that the level of MMP-1, MMP-9 and TIMP-1 in obese patients with BA can serve as biomarkers of airway remodeling, namely, the severity and the level of BA control.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 50 条
  • [31] URINARY MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR MATRIX METALLOPROTEINASE-1 IN CHILDREN WITH URETEROPELVIC JUNCTION OBSTRUCTION
    Li, Zhenzhen
    Wen, Jianguo
    Shi, Hufeng
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 537 - 537
  • [32] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure - Reply
    Fonarow, Gregg C.
    Horwich, Tamara B.
    Eshaghian, Shervin
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [33] Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
    Madjid, Tita Husnitawati
    Ardiansyah, Dennis Fachmi
    Permadi, Wiryawan
    Hernowo, Bethy
    [J]. DIAGNOSTICS, 2020, 10 (06)
  • [34] Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
    Guzel, Savas
    Serin, Ozden
    Guzel, Eda Celik
    Buyuk, Banu
    Yilmaz, Guzin
    Guvenen, Guvenc
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2013, 28 (02): : 165 - 173
  • [35] Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
    Bojic, Suzana
    Kotur-Stevuljevic, Jelena
    Aleksic, Aleksandra
    Gacic, Jasna
    Memon, Lidija
    Simic-Ogrizovic, Sanja
    [J]. DISEASE MARKERS, 2018, 2018
  • [36] The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia
    Choi, KH
    Lee, HB
    Jeong, MY
    Rhee, YK
    Chung, MJ
    Kwak, YG
    Lee, YC
    [J]. CHEST, 2002, 121 (05) : 1478 - 1485
  • [37] Expression of collagenases (matrix metalloproteinase-1, 8, 13) and tissue inhibitor of metalloproteinase-1 of retrodiscal tissue in temporomandibular joint disorder patients
    Gho, Won Gyung
    Choi, Yuri
    Park, Kwang-Ho
    Huh, Jong-Ki
    [J]. JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2018, 44 (03) : 120 - 127
  • [38] Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma
    Babichenko, Igor I.
    Andriukhin, Mikhail I.
    Pulbere, Sergey
    Loktev, Artem
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 9090 - 9098
  • [39] Differential expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 by human vascular smooth muscle cells
    Kato, S
    Yasukawa, H
    Fujii, T
    Miyagi, M
    Nishi, M
    Morimatsu, M
    Miyamoto, T
    Fox, JC
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 251 - 251
  • [40] Effect of estrogen on the expression of matrix metalloproteinase-1,-3, and tissue inhibitor of metalloproteinase-1 in osteoarthritis chondrocyte.
    Lee, YJ
    Kwon, YE
    Lee, JJ
    Lee, EB
    Song, YW
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S61 - S61